Bio-Medical Applications Of New Hampshire Inc in Salem, New Hampshire - Dialysis Center

Bio-Medical Applications Of New Hampshire Inc is a medicare approved dialysis facility center in Salem, New Hampshire and it has 1 dialysis stations. It is located in Rockingham county at 19 Keewadin Drive Suite 1, Salem, NH, 03079. You can reach out to the office of Bio-Medical Applications Of New Hampshire Inc at (603) 870-0969. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of New Hampshire Inc has the following ownership type - Profit. It was first certified by medicare in February, 2014. The medicare id for this facility is 302516 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of New Hampshire Inc
Location19 Keewadin Drive Suite 1, Salem, New Hampshire
No. of Dialysis Stations 1
Medicare ID302516
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


19 Keewadin Drive Suite 1, Salem, New Hampshire, 03079
(603) 870-0969

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of New Hampshire Inc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1891120812
Organization NameFresenius Medical Care Rockingham County
Doing Business AsBio-medical Applications Of New Hampshire, Inc.
Address19 Keewaydin Dr Salem, New Hampshire, 03079
Phone Number(603) 870-0969

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data34
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL12

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center46
    Adult patient months included in Kt/V greater than or equal to 1.2393
    Percentage of adult patients getting regular hemodialysis at the center97
  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center8
    Adult patient months included in Kt/V greater than or equal to 1.778

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of New Hampshire Inc with elevated calcium levels.

Patients with hypercalcemia57
Hypercalcemia patient months509
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor64
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL33
Patients with Serumphosphor from 4.6 to 5.5 mg/dL31
Patients with Serumphosphor from 5.6 to 7 mg/dL18
Patients with Serumphosphor greater than 7 mg/dL11

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 53
Patient months included in arterial venous fistula and catheter summaries 399
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer20

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary49
Hospitalization Rate in facility205 (As Expected)
Hospitalization Rate: Upper Confidence Limit344.9
Hospitalization Rate: Lower Confidence Limit126.4

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of New Hampshire Inc were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility24.7 (As Expected)
Readmission Rate: Upper Confidence Limit36.2
Readmission Rate: Lower Confidence Limit15.2

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Bio-Medical Applications Of New Hampshire Inc get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
SIR: Upper Confidence Limit.98

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applications Of New Hampshire Inc's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 36
Transfusion Rate in facility45.6 (As Expected)
Transfusion Rate: Upper Confidence Limit139.4
Transfusion Rate: Lower Confidence Limit17.1

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applications Of New Hampshire Inc lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary129
Mortality Rate in facility19.8 (As Expected)
Mortality Rate: Upper Confidence Limit30.9
Mortality Rate: Lower Confidence Limit11.9

Dialysis Facility in Salem, NH

Bio-Medical Applications Of New Hampshire Inc
Location: 19 Keewadin Drive Suite 1, Salem, New Hampshire, 03079
Phone: (603) 870-0969
Versailles Dialysis Llc
Location: 18 Pelham Road, Salem, New Hampshire, 03079
Phone: (603) 870-9487

Medicare Program: Medicare is a federal government program which provides health insurance to people who are 65 or older. This program also covers certain younger people with disabilities (who receive Social Security Disability Insurance - SSDI), and people with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant, sometimes called ESRD.

Medicare Assignment: Assignment means that your doctor, provider, or supplier agrees (or is required by law) to accept the Medicare-approved amount as full payment for covered services. Most doctors, providers, and suppliers accept assignment, but you should always check to make sure. Participating providers have signed an agreement to accept assignment for all Medicare-covered services.

NPI Number: The National Provider Identifier (NPI) is a unique identification number for covered health care providers. The NPI must be used in lieu of legacy provider identifiers in the HIPAA standards transactions. Covered health care providers and all health plans and health care clearinghouses must use the NPIs in the administrative and financial transactions adopted under HIPAA (Health Insurance Portability and Accountability Act).

Our Data: Information on www.medicarelist.com is built using data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA). The information disclosed on the NPI Registry are FOIA-disclosable and are required to be disclosed under the FOIA and the eFOIA amendments to the FOIA. There is no way to 'opt out' or 'suppress' the NPPES record data for health care providers with active NPIs.